Navigation Links
Commonly used catheter's safety tied to patient population
Date:8/6/2013

CHICAGO (August 6, 2013) A new study reports that peripherally inserted central catheters (PICCs) do not reduce the risk of central line associated bloodstream infections (CLABSIs) in hospitalized patients. PICCs have become one of the most commonly used central venous catheters (CVCs) in healthcare settings since they are considered easier and safer to use, with less risk of CLABSIs. The study, published in the September issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America, demonstrates that the risk of CLABSI with PICCs is based more on patient factors, rather than the device.

"As the use of PICCs has grown exponentially in vulnerable populations, caution and close evaluation of risks and benefits is warranted when using the device," said Vineet Chopra, MD, MSc, lead author of the study and assistant professor of medicine at the University of Michigan Health System. "This research provides novel ideas for advancing both clinical practice and science around the use of these devices."

Chopra and colleagues conducted a systematic review and meta-analysis of 23 studies of PICCs to compare the risk of CLABSIs between PICCs and other non-cuffed, non-tunneled central venous catheters (CVCs). The researchers hypothesized that selection of healthier patients in past studies may explain the lower risk of CLABSI observed with PICCs. Their theory was based on the observation that many of the original studies reporting PICC bloodstream infection rates included non-hospitalized patients who are fundamentally different from those in whom CLABSIs usually occur.

The analysis involved 57,250 patients and revealed that hospitalized patients with PICCs were just as likely to develop bloodstream infection when compared with patients with other types of CVCs; however, non-hospitalized patients in outpatient settings appeared to fare better with PICCs than other devices.

The authors suggest adhering to proven prevention strategies to reduce CLABSIs in non-critical care settings with the same drive, intensity, and strategic insights that have been employed in intensive care units. The study also highlights the need for future research assessing the role of novel technologies and practices, such as chlorhexidine-impregnated site dressings and antimicrobial PICCs.


'/>"/>

Contact: Tamara Moore
tmoore@gymr.com
202-745-5114
Society for Healthcare Epidemiology of America
Source:Eurekalert

Related medicine news :

1. Commonly Prescribed Drugs May Influence the Onset and Progression of Alzheimer’s Disease
2. Commonly-prescribed drugs may influence the onset and progression of Alzheimers disease
3. Middle-aged women commonly become ill with stress
4. Commonly used drug can limit radiation damage to lungs and heart for cancer patients
5. Commonly used cholesterol calculation underestimates heart disease danger for many
6. UV Flash Infection Control Unit Steps onto the Healthcare Market, with a Quick and Effective Way to Disinfect Virtually any Item Commonly Found in Medical Facilities
7. New UAlberta research shows commonly prescribed medications could have adverse effects
8. Condition Commonly Seen in Aging May Alter Brain Function
9. Commonly used painkillers may protect against skin cancer
10. Global Catheters Market Will Reach USD 33.3 Billion in 2017: Transparency Market Research
11. Dialysis Catheters Tied to Higher Risk for Infection, Death, Study Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... CA (PRWEB) , ... February 23, 2017 , ... Hamlin ... to announce that they are sponsoring a raffle. Throughout the month of February, patients ... will receive a gift card for a dinner for two at the Cheesecake Factory. ...
(Date:2/23/2017)... ... February 23, 2017 , ... On April 13, 2017, ... “Doping in Sport: How the Culture Might Change,” in conjunction with ... symposium will be held at Pepperdine University in Malibu, California. , Sir Philip ...
(Date:2/23/2017)... PHILADELPHIA (PRWEB) , ... February 23, 2017 , ... ... risk and uncertainty in clinical trials, today announced that Premier Research, a leading ... management solution. , Clinical trials are becoming increasingly complex, due in part to ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... partnership with the Rhode Island Consortium for Autism Research and Treatment (RI-CART) and ... children with autism spectrum disorder (ASD) to see films in an environment that ...
(Date:2/23/2017)... Angeles, CA (PRWEB) , ... February 23, 2017 , ... ... her Smiling Patriot program today with a new Indiegogo campaign . ... care to homeless veterans in the Los Angeles area, either as a participating patient ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... 23, 2017 LG Innotek today announced that the company ... As its sterilization performance is 1.5 times higher than the competitor,s ... rays in the range of 200 -- 280nm, allowing it to be ... destroying their DNA. LG Innotek,s product emits UV in the range ... Until ...
(Date:2/23/2017)... Research and Markets has announced the addition of the "Global ... 2025" report to their offering. ... The Global Cardiac Prosthetic Devices Market is ... next decade to reach approximately $8.9 billion by 2025. ... the given segments on global as well as regional levels presented ...
(Date:2/23/2017)... February 23, 2017 Tillotts Pharma ... Berlin office was opened in ... . The portfolio includes Entocort ® for the ... treatment of ulcerative colitis, and VistaPrep ® for ... Swiss specialty pharmaceutical company focused on the treatment of ...
Breaking Medicine Technology: